Zamuner S - Search Results

1

Population model of longitudinal FEV1 data in asthmatics: meta-analysis and predictability of placebo response.

Marostica E, Russu A, Yang S, De Nicolao G, Zamuner S, Beerahee M. Marostica E, et al. Among authors: zamuner s. J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):553-69. doi: 10.1007/s10928-014-9373-1. Epub 2014 Aug 15. J Pharmacokinet Pharmacodyn. 2014. PMID: 25123552

2

A PCA approach to population analysis: with application to a Phase II depression trial.

Marostica E, Russu A, Gomeni R, Zamuner S, De Nicolao G. Marostica E, et al. Among authors: zamuner s. J Pharmacokinet Pharmacodyn. 2013 Apr;40(2):213-27. doi: 10.1007/s10928-013-9304-6. Epub 2013 Mar 17. J Pharmacokinet Pharmacodyn. 2013. PMID: 23504512 Clinical Trial.

3

Continuous-time Markov modelling of flexible-dose depression trials.

Marostica E, Russu A, Gomeni R, Zamuner S, De Nicolao G. Marostica E, et al. Among authors: zamuner s. J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):625-38. doi: 10.1007/s10928-014-9389-6. Epub 2014 Oct 4. J Pharmacokinet Pharmacodyn. 2014. PMID: 25281421

4

Population modelling of patient responses in antidepressant studies: a stochastic approach.

Marostica E, Russu A, Gomeni R, Zamuner S, De Nicolao G. Marostica E, et al. Among authors: zamuner s. Math Biosci. 2015 Mar;261:37-47. doi: 10.1016/j.mbs.2014.11.007. Epub 2014 Dec 4. Math Biosci. 2015. PMID: 25481225

5

Joint modeling of efficacy, dropout, and tolerability in flexible-dose trials: a case study in depression.

Russu A, Marostica E, De Nicolao G, Hooker AC, Poggesi I, Gomeni R, Zamuner S. Russu A, et al. Among authors: zamuner s. Clin Pharmacol Ther. 2012 May;91(5):863-71. doi: 10.1038/clpt.2011.322. Clin Pharmacol Ther. 2012. PMID: 22472989 Clinical Trial.

6

Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patients.

Bizzotto R, Zamuner S, De Nicolao G, Karlsson MO, Gomeni R. Bizzotto R, et al. Among authors: zamuner s. J Pharmacokinet Pharmacodyn. 2010 Apr;37(2):137-55. doi: 10.1007/s10928-009-9148-2. Epub 2010 Jan 6. J Pharmacokinet Pharmacodyn. 2010. PMID: 20052524 Clinical Trial.

7

MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues.

Lavezzi SM, Mezzalana E, Zamuner S, De Nicolao G, Ma P, Simeoni M. Lavezzi SM, et al. Among authors: zamuner s. J Pharmacokinet Pharmacodyn. 2018 Dec;45(6):787-802. doi: 10.1007/s10928-018-9608-7. Epub 2018 Nov 10. J Pharmacokinet Pharmacodyn. 2018. PMID: 30415351

8

Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysis.

Bizzotto R, Zamuner S, Mezzalana E, De Nicolao G, Gomeni R, Hooker AC, Karlsson MO. Bizzotto R, et al. Among authors: zamuner s. AAPS J. 2011 Sep;13(3):445-63. doi: 10.1208/s12248-011-9287-4. Epub 2011 Jun 21. AAPS J. 2011. PMID: 21691915 Free PMC article.

9

Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture.

Page KR, Mezzalana E, MacDonald AJ, Zamuner S, De Nicolao G, van Maurik A. Page KR, et al. Among authors: zamuner s. J Pharmacol Exp Ther. 2015 Nov;355(2):199-205. doi: 10.1124/jpet.115.224899. Epub 2015 Sep 4. J Pharmacol Exp Ther. 2015. PMID: 26341624

10

Adaptive-optimal design in PET occupancy studies.

Zamuner S, Di Iorio VL, Nyberg J, Gunn RN, Cunningham VJ, Gomeni R, Hooker AC. Zamuner S, et al. Clin Pharmacol Ther. 2010 May;87(5):563-71. doi: 10.1038/clpt.2010.9. Epub 2010 Mar 24. Clin Pharmacol Ther. 2010. PMID: 20336064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters